Literature DB >> 7281907

[Intraosseous lipomas (author's transl)].

R Döhler, D Harms.   

Abstract

This is a report on four intraosseous lipomas. One in the tibia diapysis of an infant, one in the fibula head, one in the proximal epimetaphysis of the humerus, and one in the calcaneus of three adults. Together with fourty-two intraosseous lipomas which have been reported by other authors, they are evaluated via clinical, radiological, and pathological aspects. The metaphyses of long bones and the calcaneus are common localizations of intraosseous lipomas. There may be no clinical symptoms or non-specific ones. The history may last for decades. Trabecular structures are noted usually on x-ray and almost always on histological examination. A capsule, capillaries, and the lack of sinusoids and haemopoietic bone marrow demonstrate the neoplastic nature of intraosseous lipomas. Because of their good prognosis intraosseous lipomas may be treated conservatively or by curettage.

Entities:  

Mesh:

Year:  1981        PMID: 7281907     DOI: 10.1055/s-2008-1051435

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  4 in total

1.  Case report 377: Intraosseous lipoma (angiolipoma) of right third rib.

Authors:  F M Hall; R B Cohen; K Grumbach
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

2.  Multiple Intraosseous Lipomatosis - A Case Report and a Review of the Literature.

Authors:  Dietmar Dammerer; Johannes Neugebauer; David Putzer; Benjamin Henninger
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  [Surgical indications in intraosseous lipoma of the calcaneus. Case report and critical review of the literature].

Authors:  M Neuber; J Heier; T Vordemvenne; M Schult
Journal:  Unfallchirurg       Date:  2004-01       Impact factor: 1.000

4.  Hibernoma-like brown fat in the bone marrow: report of a unique case.

Authors:  C Thorns; C Schardt; D Katenkamp; C Kähler; H Merz; A C Feller
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.